by Mark Lane mark@nullmoodiedavittreport.com Source: ©The Moodie Davitt Report 28 October 2020
USA. XpresSpa Group’s new XpresCheck COVID-19 testing facility is now open to Boston Logan International Airport employees and will be fully operational for passengers by mid-November.
Introduced via MarketPlace Logan – an affiliate of Boston-based New England Development and manager of the Boston Logan Concessions Program – the facility is located in the International Arrival area in Terminal E (pre-security), with seven separate testing rooms.
It can administer more than 400 tests a day for passengers arriving and departing the airport within all terminals, as well as airport employees.
There are three COVID-19 testing options in the form of the rapid molecular COVID-19 test, the polymerase chain reaction (PCR) test, and a blood antibody test.
Airport employees and travellers can visit the XpresCheck facility via walk-in appointments or by advance booking. Prices range from US$75 for an individual PCR test or individual blood antibody test, to US$90 for both.
XpresCheck also accepts insurance for the individual PCR and blood antibody test. The entire testing process, including introductions, administering the test, and the clinical visit, takes up to about 20 minutes and results are provided on-site if having the rapid molecular COVID-19 test. Alternatively, results can be shared via XpresCheck’s secure patient portal.
MarketPlace Development President Paul McGinn said: “I am very excited about this new service that has opened in Terminal E. By expanding our preventative measures and adapting to new technology with the arrival of XpresCheck, we remain committed to ensuring the health and safety of our passengers and employees.”
He added: “Having easy access to a testing site at the airport will continue to provide a further sense of security for those who travel through Boston Logan now or in the future.”
XpresSpa Chief Executive Doug Satzman said: “We are thrilled to be opening XpresCheck today at Logan International Airport, which is our first testing facility outside of the New York metro area, and third to date.
“Our strategy remains focused on XpresCheck’s national expansion and we are in active discussions with other airports for further development of this highly relevant and timely concept. We anticipate announcing additional openings in the coming weeks.”